Skip to main content
Are three drugs for malaria better than two?
A shorter course for anti-relapse therapy against vivax malaria.
Gender norms and health: insights from global survey data.
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial.
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study.
Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
Prediction of complicated disease course for children newly diagnosed with Crohn's disease: a multicentre inception cohort study.
Home use of a bihormonal bionic pancreas versus insulin pump therapy in adults with type 1 diabetes: a multicentre randomised crossover trial.
Palatal fistula risk after primary palatoplasty: a retrospective comparison of humanitarian operations and tertiary hospitals.
The changing epidemiology of malaria elimination: new strategies for new challenges.